Seeking Alpha

Two healthcare names on the move thanks to Barron's

  • BioScrip (BIOS +5.3%) gets an early pop following a big thumbs up from Oscar Schafer in the Barron's Roundtable over the weekend. Also gaining after getting picked by Schafer is ANI Pharmaceuticals (ANIP +6.3%).
  • Now alone in the market for its estrogen product, ANI has been able to boost prices, and - combined with the acquisition of 31 generic products from Teva Pharmaceutical - the company could earn more than $1 per share this year, rising to $2 over time. "The key is to grow the portfolio from seven drugs to more than 30, and buy additional drugs."
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|